Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.
N Engl J Med. 2015 Jan 8;372(2):134-41. doi: 10.1056/NEJMoa1406281.
N Engl J Med. 2015.
PMID: 25564897
Free PMC article.
Clinical Trial.